The Efficacy of Propranolol in Retinopathy of Prematurity and its Correlation with the Platelet Mass Index (Q36040633)

11 August 2017

The Efficacy of Propranolol in Retinopathy of Prematurity and its Correlation with the Platelet Mass Index (English)

1 reference

retinopathy of prematurity

11 August 2017

1 reference

Levent Korkmaz

1

1 reference

11 August 2017

Osman Baştuğ

2

1 reference

11 August 2017

Ahmet Ozdemir

3

1 reference

11 August 2017

Sabriye Korkut

4

1 reference

11 August 2017

Cagatay Karaca

5

1 reference

11 August 2017

Mustafa Ali Akin

6

1 reference

11 August 2017

Tamer Gunes

7

1 reference

11 August 2017

Selim Kurtoglu

8

1 reference

11 August 2017

Mehmet Adnan Ozturk

9

1 reference

11 August 2017

3 June 2016

1 reference

11 August 2017

1 reference

11 August 2017

42

1 reference

11 August 2017

1

1 reference

11 August 2017

88-97

1 reference

Variations in practice and outcomes in the Canadian NICU network: 1996-1997.

11 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Pathological basis of retrolental fibroplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Pathogenesis of retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Through the eyes of a child: understanding retinopathy through ROP the Friedenwald lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Propranolol induces regression of hemangioma cells through HIF-1α-mediated inhibition of VEGF-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Investigating the Association between Angiogenic Cytokines and Corneal Neovascularization in Sulfur Mustard Intoxicated Subjects 26 Years after Exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Grating visual acuity results in the early treatment for retinopathy of prematurity study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

On safety, pharmacokinetics and dosage of bevacizumab in ROP treatment - a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Intravitreal bevacizumab for retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Propranolol for severe hemangiomas of infancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Perinatal infection, inflammation, and retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Mechanisms and management of retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

The neurovascular retina in retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Long term functional and structural outcomes of laser therapy for retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Antiangiogenic effects of β2 -adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Retinopathy of prematurity and pulse oximetry: a national survey of recent practices

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Risk factors of retinopathy of prematurity in premature infants weighing less than 1600 g.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Survey on retinopathy of prematurity (ROP) in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

High or low oxygen saturation and severe retinopathy of prematurity: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Fungal and bacterial sepsis and threshold ROP in preterm very low birth weight neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Association of postnatal dexamethasone use and fungal sepsis in the development of severe retinopathy of prematurity and progression to laser therapy in extremely low-birth-weight infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Effects of maternal and placental inflammation on retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Maternal preeclampsia is associated with an increased risk of retinopathy of prematurity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Neonatal outcome of temporizing treatment in early-onset preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Preeclampsia and retinopathy of prematurity in preterm births.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Decreased incidence of retinopathy of prematurity, 1995-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Antenatal dexamethasone and decreased severity of retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Postnatal dexamethasone treatment and retinopathy of prematurity in very-low-birth-weight neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

10.3109/02713683.2016.1158272

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference